Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study. [electronic resource]
Producer: 20171016Description: 103-109 p. digitalISSN:- 1757-7861
- Absorptiometry, Photon -- methods
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling -- drug effects
- Diphosphonates -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Female
- Hip Joint -- physiopathology
- Humans
- Imidazoles -- administration & dosage
- Infusions, Intravenous
- Lumbar Vertebrae -- physiopathology
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Osteoporotic Fractures -- prevention & control
- Secondary Prevention -- methods
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.